Tyra Biosciences, Inc. (TYRA) — Stock Score Summary

Tyra Biosciences, Inc. (TYRA) has a MoatMap StockRank of 42/100 based on Quality (40/100), Value (35/100), and Momentum (54/100) factor scores. The current signal is HOLD. Tyra Biosciences is a clinical-stage biotech company; despite promising FGFR biology, it does not meet our criteria for established cash flows and structural moats.

Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing precision medicines for patients with a variety of cancers, particularly those with acquired resistance to existing therapies. The company's competitive moat is underpinned by its proprietary SNF platform, enabling the discovery of highly selective small molecule inhibitors targeting resistance mutations in oncology. Tyra Biosciences is positioned as an innovator in addressing the challenge of drug resistance in cancer treatment.

Key Financial Metrics

Price$25.94
Market Cap$1.9B
P/E (Forward)-9.58
Price/Book5.63
Return on Equity-36.9%
Return on Invested Capital-50.2%
Debt/Equity1.47
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-60M

Tyra Biosciences, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Tyra Biosciences, Inc.’s (TYRA) StockRank?
MoatMap’s StockRank for Tyra Biosciences, Inc. (TYRA) is 42/100, with a Hold signal. It is a composite of Quality (40), Value (35), and Momentum (54) factor ranks across MoatMap’s 19,000+ stock universe.
Does Tyra Biosciences, Inc. have an economic moat?
Tyra Biosciences, Inc. (TYRA) has a Quality factor score of 40/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tyra Biosciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Tyra Biosciences, Inc. (TYRA) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tyra Biosciences, Inc. in?
Tyra Biosciences, Inc. (TYRA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksTYRA deep dive reportAI ChampionsHow we score stocksSense-check another stock